AstraZeneca PLC

AZNNYSE • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
185.95 USD
↗ 4.15 (2.28%)AT CLOSE (11:59 AM EDT)
185.74
↘ 0.21 (0.11%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
185.74
↘ 0.21 (0.11%)
🔴Market: CLOSED
Open?$184.02
High?$186.12
Low?$184.02
Prev. Close?$181.80
Volume?2.3M
Avg. Volume?2.1M
VWAP?$185.25
Rel. Volume?1.13x
Bid / Ask
Bid?$182.04 × 100
Ask?$186.39 × 300
Spread?$4.35
Midpoint?$184.21
Valuation & Ratios
Market Cap?281.9B
Shares Out?N/A
P/E Ratio?194.31
P/B Ratio?18.98
EPS?$0.94
Dividend?0.00%
Ex-Dividend?N/A

Shares of AstraZeneca PLC (AZN) are trading at $185.95. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9 and a bullish Golden Cross on the moving averages. On the valuation front, AZN trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Metabolic & CardiometabolicHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
96.1K
Market Cap
281.9B
Industry
N/A
Website
www.astrazeneca.com
Listed
2009-10-23
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
97
Momentum?
50
Short Sent.?
43
Piotroski F-Score?0/9Weak
Altman Z-Score?4.73Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestLow
Short Interest?2.2M
Days to Cover?1.2
Avg Daily Volume1.8M
Settlement Date2026-05-15
Financial Health
Current Ratio?0.87Weak
Quick Ratio?0.72Weak
Cash Ratio?0.33Low
Debt/Equity?1.77High
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score
33/100
P/E?
Peers
11
S&P
3
194.3PRICEY▾
P/B?
Peers
33
S&P
8
18.98HIGH▾
P/S?
Peers
9
S&P
3
15.56HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
10
S&P
3
84.6HIGH▾
EV/Sales?
Peers
9
S&P
3
16.74HIGH▾
Returns & Efficiency
ROE?
Peers
33
S&P
33
9.8%FAIR▾
ROA?
Peers
11
S&P
22
2.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$303.2B
Fundamentals ratios updated end of day
MarketsMoversWatchlist